Form 4: Snap-on CFO Exercises Options, Sells Shares
Insider Transaction Report
Snap-on Inc.'s Senior VP of Finance and CFO, Aldo J. Pagliari, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 plan.
Summary
- Aldo J. Pagliari, Senior VP Finance & CFO of Snap-on Inc. (SNA), executed transactions on December 11, 2025, under a Rule 10b5-1 Plan adopted on October 22, 2024.
- Pagliari exercised 10,000 stock options at an exercise price of $138.03 per share.
- A total of 6,779 shares of common stock were sold in multiple trades at weighted average prices ranging from $349.6455 to $353.6129.
- The transactions resulted in a decrease in direct beneficial ownership of common stock from 118,667.0556 shares to 111,888.0556 shares.
- The reported beneficial ownership includes 19.0004 shares acquired under a dividend reinvestment plan.
- Pagliari retains significant derivative holdings, including various stock options, restricted stock units, and performance units with future vesting and expiration dates.
Sentiment
Score: 5
Explanation: The filing reports a routine, pre-planned insider transaction (option exercise and subsequent sale) under a 10b5-1 plan. This type of transaction is generally neutral in sentiment as it reflects personal financial planning rather than a reaction to new company-specific positive or negative news.
Positives
- The executive exercised options at a significantly lower price ($138.03) compared to the sale prices (ranging from approximately $349 to $353), indicating a profitable transaction for the executive.
- Transactions were conducted under a pre-arranged Rule 10b5-1 plan, suggesting a routine liquidity event rather than a reaction to new, negative company information.
- The executive retains a substantial beneficial ownership of 111,888.0556 common shares, plus significant derivative holdings, demonstrating continued alignment with shareholder interests.
- Acquisition of 19.0004 shares through a dividend reinvestment plan indicates continued participation in the company's dividend program.
Negatives
- The sale of 6,779 shares of common stock, even if pre-planned, represents a reduction in the executive's direct equity stake in the company.
Risks
- Market price fluctuations could impact the value of the executive's remaining stock options, restricted stock units, and performance units.
- Failure of the company to achieve certain performance goals could result in a lower number of shares awarded from performance units.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports insider transactions and holdings.
Industry Context
This Form 4 filing details a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption | The adoption of a Rule 10b5-1 Plan on October 22, 2024, demonstrates adherence to insider trading regulations by pre-arranging transactions to avoid accusations of trading on material non-public information. | October 22, 2024 | Enhances transparency and reduces potential for insider trading concerns by establishing a pre-scheduled trading plan for executives. |
Stakeholder Impact
- Shareholders: The transaction is a routine insider sale under a pre-arranged plan, which typically has minimal direct impact on shareholders. The executive retains significant holdings, indicating continued alignment.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- Vesting of remaining Restricted Stock Units on their respective dates (e.g., February 9, 2026; February 15, 2027; February 13, 2028).
- Potential award of shares from Performance Units based on company goal achievement over the 2023-2025, 2024-2026, and 2025-2027 periods.
Key Dates
| Date | Description |
|---|---|
| February 27, 2019 | Date Power of Attorney was executed by Aldo J. Pagliari. |
| October 22, 2024 | Date Rule 10b5-1 Plan was adopted by Aldo J. Pagliari. |
| December 11, 2025 | Date of stock option exercise and common stock sales by Aldo J. Pagliari. |
| February 9, 2026 | Vesting date for 1,793 Restricted Stock Units and date exercisable for 5,342 Stock Options. |
| February 11, 2026 | Expiration date for the 10,000 stock options that were exercised. |
| February 15, 2027 | Vesting date for 1,533 Restricted Stock Units. |
| February 9, 2027 | Expiration date for 36,000 Stock Options with an exercise price of $168.7. |
| February 13, 2028 | Vesting date for 1,249 Restricted Stock Units. |
| February 15, 2028 | Expiration date for 26,052 Stock Options with an exercise price of $161.18. |
| February 14, 2029 | Expiration date for 23,500 Stock Options with an exercise price of $155.92. |
| February 13, 2030 | Expiration date for 23,500 Stock Options with an exercise price of $155.34. |
| February 11, 2031 | Expiration date for 14,986 Stock Options with an exercise price of $189.89. |
| February 10, 2032 | Expiration date for 11,252 Stock Options with an exercise price of $211.67. |
| February 9, 2033 | Expiration date for 7,850 Stock Options with an exercise price of $249.26. |
| February 15, 2034 | Expiration date for 7,106 Stock Options with an exercise price of $269. |
| February 13, 2035 | Expiration date for 5,342 Stock Options with an exercise price of $339.73. |
Keywords
Snap-on, SNA, Form 4, Insider Transaction, Stock Options, Share Sale, Executive Compensation, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.